Literature DB >> 7532807

Assessment of the brain areas perfused by superselective intra-arterial chemotherapy using single photon emission computed tomography with technetium-99m-hexamethyl-propyleneamine oxime--technical note.

H Namba1, S Kobayashi, Y Iwadate, T Saegusa, A Sato, Y Watanabe, K Sueyoshi.   

Abstract

The brain areas perfused by superselective intra-arterial (i.a.) chemotherapy were assessed using single photon emission computed tomography (SPECT) with technetium-99m-hexamethyl-propyleneamine oxime (99mTc-HMPAO). A superselective catheter was introduced into the anterior, middle, or posterior cerebral artery of patients with malignant glioma for i.a. chemotherapy. 99mTc-HMPAO was subsequently injected via the same catheter used for chemotherapy, and a higher dose of 99mTc-HMPAO was injected intravenously to obtain adequate background brain images. Comparison of the SPECT images with magnetic resonance images could confirm complete perfusion of the tumor tissue. In two patients with malignant glioma, regions of interest were selected in the peritumoral brain area and a reference brain area, and the radioactivity was measured. The concentration of 99mTc-HMPAO was about 50 times higher in tissue perfused by superselective injection into anterior or middle cerebral artery compared to intravenous injection. 99mTc-HMPAO SPECT is readily available in many institutions and the information provided is useful for planning more effective and safe i.a. chemotherapy.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7532807     DOI: 10.2176/nmc.34.832

Source DB:  PubMed          Journal:  Neurol Med Chir (Tokyo)        ISSN: 0470-8105            Impact factor:   1.742


  4 in total

Review 1.  Intra-arterial neuroprotective therapy as an adjunct to endovascular intervention in acute ischemic stroke: A review of the literature and future directions.

Authors:  Thomas W Link; Alejandro Santillan; Athos Patsalides
Journal:  Interv Neuroradiol       Date:  2020-05-19       Impact factor: 1.610

2.  Safety and maximum tolerated dose of superselective intraarterial cerebral infusion of bevacizumab after osmotic blood-brain barrier disruption for recurrent malignant glioma. Clinical article.

Authors:  John A Boockvar; Apostolos J Tsiouris; Christoph P Hofstetter; Ilhami Kovanlikaya; Sherese Fralin; Kartik Kesavabhotla; Stephen M Seedial; Susan C Pannullo; Theodore H Schwartz; Philip Stieg; Robert D Zimmerman; Jared Knopman; Ronald J Scheff; Paul Christos; Shankar Vallabhajosula; Howard A Riina
Journal:  J Neurosurg       Date:  2010-10-22       Impact factor: 5.115

3.  Superselective intraarterial cerebral infusion of cetuximab after osmotic blood/brain barrier disruption for recurrent malignant glioma: phase I study.

Authors:  Shamik Chakraborty; Christopher G Filippi; Tamika Wong; Ashley Ray; Sherese Fralin; A John Tsiouris; Bidyut Praminick; Alexis Demopoulos; Heather J McCrea; Imithri Bodhinayake; Rafael Ortiz; David J Langer; John A Boockvar
Journal:  J Neurooncol       Date:  2016-03-05       Impact factor: 4.130

4.  Selective intra-arterial administration of ¹⁸F-FDG to the rat brain -- effects on hemispheric uptake.

Authors:  Fabian Arnberg; Erik Samén; Johan Lundberg; Li Lu; Jonas Grafström; Michael Söderman; Sharon Stone-Elander; Staffan Holmin
Journal:  Neuroradiology       Date:  2014-02-14       Impact factor: 2.804

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.